Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer
Summary
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Proposals should focus on one or more cancer types and address only one of the following interventions:
- Building on data from existing or newly established AYA patient cohorts, ensuring comparability of data across participating countries as appropriate, obtain a thorough assessment by cancer type of the prevalence, specific effect(s), severity, time of onset, relative risk, and risk factors associated to late effects in AYA cancer patients. Attention should be paid also to social and health determinants, including sex, gender, age and other relevant variables, including socio-economic status, living in rural or remote areas and education;
- Develop, test and scale-up evidence-based screening methods for the early detection of late-effects in AYA cancer patients;
- Develop, test and scale up in real-life settings, innovative, holistic approaches and tools (including digital tools), optimising cancer treatment and follow-up regimens to prevent, reduce and/or effectively manage late-effects, including psycho-social aspects. Approaches could focus on education, sports, nutrition, medical follow-up and counselling, for example on mental and physical health, pain management, and wellbeing in general, as well as reproductive matters, including infertility, onco-fertility and fertility options in general and development of effective methods for fertility preservation and guidelines on related counselling.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
Expected EU contribution per project: between €4.00 and €6.00 million
Programme Category
EU Competitive ProgrammesTotal Budget
€36.00 millionThematic Categories
- Health
- Research, Technological Development and Innovation
- Youth
Eligibility for Participation
- Associations
- NGOs
- Non Profit Organisations
- Researchers/Research Centers/Institutions
- State-owned Enterprises
- Youth
Call Opening Date
18/04/2024Call Closing Date
18/09/2024National Contact Point(s)
Research and Innovation Foundation
Address: 29a Andrea Michalakopoulou, 1075 Nicosia, P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Website: https://www.research.org.cy/en/
Persons to Contact:
Mission for the Cancer
George Christou
Scientific Officer
Email: gchristou@research.org.cy
